CTU: A Phase 1a/1b Study of ELVN-002 for the Treatment of Patients with HER2 Mutant Non-Small Cell Lung Cancer

  • Sabanathan, Dhanusha (Primary Chief Investigator)
  • Contacos, Christine (Clinical Trial Unit Staff)
  • Keshiya, Shikara (Clinical Trial Unit Staff)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • TAIDI, Gina (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleELVN-002-001
AcronymELVN-002-001
StatusActive
Effective start/end date13/06/23 → 12/06/28